Vivani Medical
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 44
- Market Cap
- $74.5M
- Website
- http://www.vivani.com
- Introduction
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
Phase 1
Not yet recruiting
- Conditions
- Overweight and ObesityType2diabetes
- Interventions
- Drug: Semaglutide, 1.0 mg/mLCombination Product: Exenatide ImplantDrug: Bydureon BCise (exenatide extended release)
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Vivani Medical, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT05670379
© Copyright 2025. All Rights Reserved by MedPath